| scholarly article | Q13442814 |
| P2093 | author name string | Juan Martin Palomo | |
| Abbas R Zaher | |||
| Leena Palomo | |||
| Mohamed G Hassan | |||
| P2860 | cites work | Osteocyte control of bone formation via sclerostin, a novel BMP antagonist | Q24300347 |
| IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis | Q24563235 | ||
| Osteocytes and WNT: the mechanical control of bone formation. | Q37702067 | ||
| Sclerostin: recent advances and clinical implications | Q38261694 | ||
| Accelerated orthodontic tooth movement: molecular mechanisms | Q38273518 | ||
| Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial | Q38400853 | ||
| Gingival crevicular fluid bone turnover biomarkers: How postmenopausal women respond to orthodontic activation | Q38666472 | ||
| Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases | Q38786719 | ||
| Modulation of matrix metalloproteinase and cytokine production by licorice isolates licoricidin and licorisoflavan A: potential therapeutic approach for periodontitis | Q39665753 | ||
| Mechanically stimulated osteocytes regulate osteoblastic activity via gap junctions | Q40248461 | ||
| The sclerostin-bone protein interactome | Q40432910 | ||
| Remodelling of collagen fibers in the periodontal ligament and the supra-alveolar region | Q40613010 | ||
| Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis | Q41149698 | ||
| Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro | Q43271941 | ||
| Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic | Q43968160 | ||
| Ten years' experience with alendronate for osteoporosis in postmenopausal women | Q44804093 | ||
| Teriparatide and osseous regeneration in the oral cavity | Q47136107 | ||
| Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling | Q47871615 | ||
| Contribution of biomechanical forces to inflammation-induced bone resorption | Q48314878 | ||
| Host modulation therapy with anti-inflammatory agents | Q48585276 | ||
| The amazing osteocyte | Q24635849 | ||
| Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation | Q28267745 | ||
| Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation | Q28269067 | ||
| Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength | Q28274891 | ||
| Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody | Q28286616 | ||
| Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis | Q28302443 | ||
| Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review | Q31048527 | ||
| Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation | Q32062865 | ||
| Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women | Q33786865 | ||
| Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults | Q34047520 | ||
| Sclerostin | Q34211729 | ||
| Tissue reaction to orthodontic tooth movement--a new paradigm | Q34559607 | ||
| Effect of orthodontic forces on cytokine and receptor levels in gingival crevicular fluid: a systematic review | Q34657931 | ||
| COLLAGEN AND BONE. | Q35435662 | ||
| Bisphosphonate therapy in the oncology setting | Q35602668 | ||
| Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012 | Q35701443 | ||
| Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases | Q35762495 | ||
| Removal of SOST or blocking its product sclerostin rescues defects in the periodontitis mouse model | Q35774786 | ||
| Cytokine expression and accelerated tooth movement | Q35866637 | ||
| SOST/sclerostin, an osteocyte-derived negative regulator of bone formation | Q36115718 | ||
| The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). | Q36190027 | ||
| The association between osteoporosis and oral bone loss | Q36309256 | ||
| Bisphosphonates for malignancy-related bone disease: current status, future developments | Q36383420 | ||
| Osteocytes, mechanosensing and Wnt signaling | Q36595560 | ||
| Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton | Q36774955 | ||
| Oral fluid-based biomarkers of alveolar bone loss in periodontitis. | Q36792245 | ||
| The relation between renal function and serum sclerostin in adult patients with CKD. | Q36810475 | ||
| RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. | Q36973041 | ||
| Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. | Q37091516 | ||
| Mechanobiology of tooth movement | Q37186468 | ||
| RANK/RANKL/OPG during orthodontic tooth movement | Q37472206 | ||
| Osteocyte-driven bone remodeling | Q37626024 | ||
| Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats. | Q50574453 | ||
| Saturation of the biological response to orthodontic forces and its effect on the rate of tooth movement. | Q50592066 | ||
| Sclerostin antibody stimulates bone regeneration after experimental periodontitis. | Q50956663 | ||
| Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy. | Q51812224 | ||
| Changes in the spatial distribution of sclerostin in the osteocytic lacuno-canalicular system in alveolar bone due to orthodontic forces, as detected on multimodal confocal fluorescence imaging analyses. | Q53016716 | ||
| Receptor activator of nuclear factor-κB ligand and sclerostin expression in osteocytes of alveolar bone in rats with ligature-induced periodontitis. | Q53031123 | ||
| Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. | Q53777467 | ||
| Sclerostin in Mineralized Matrices and van Buchem Disease | Q57848944 | ||
| Effect of cytokines on osteoclast formation and bone resorption during mechanical force loading of the periodontal membrane | Q59100551 | ||
| Gingival fluid IL-1 beta and IL-6 levels in menopause | Q72288376 | ||
| Chemokines are upregulated during orthodontic tooth movement | Q73040018 | ||
| TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype | Q73112905 | ||
| Biological reaction of alveolar bone to orthodontic tooth movement | Q77398070 | ||
| Mechanical stimulation in vivo reduces osteocyte expression of sclerostin | Q79448199 | ||
| Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones | Q84033150 | ||
| Induction of cytokines, MMP9, TIMPs, RANKL and OPG during orthodontic tooth movement | Q84985728 | ||
| Kinetics of interleukin-6 and chemokine ligands 2 and 3 expression of periodontal tissues during orthodontic tooth movement | Q85015506 | ||
| The role of osteocytes in bone resorption during orthodontic tooth movement | Q85991589 | ||
| Gingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin, and Receptor Activator of Nuclear Factor-κB Ligand in Periodontitis | Q86137339 | ||
| Bone matrix quality after sclerostin antibody treatment | Q87177089 | ||
| Experimental model of tooth movement in mice: a standardized protocol for studying bone remodeling under compression and tensile strains | Q87409994 | ||
| Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients | Q87436498 | ||
| Periodontal cytokines profile under orthodontic force and extracorporeal shock wave stimuli in a rat model | Q87466465 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 134 | |
| P577 | publication date | 2018-11-23 | |
| P1433 | published in | Healthcare | Q27726790 |
| P1476 | title | Sclerostin Modulation Holds Promise for Dental Indications | |
| P478 | volume | 6 |
Search more.